文献速递儿科与产科急症

连续两次妊娠接种季节性流感疫苗的安全性

Safety of the Seasonal Influenza Vaccine in 2 Successive Pregnancies.
PubMed 文献 · JAMA Netw Open · 2024-09-03
一句话结论大型回顾性队列显示连续两次妊娠接种流感疫苗未增加不良围产结局风险,支持妊娠期接种建议。

该回顾性队列研究基于疫苗安全数据链(Vaccine Safety Datalink),纳入2004年1月1日至2018年12月31日间至少两次连续单胎活产的82055人,其中44879人(54.7%)在连续两次妊娠的流感季节(8月1日至4月30日)均接种流感疫苗。与两次妊娠均未接种者相比,连续接种与子痫前期或子痫(调整RR 1.10;95%CI 0.99-1.21)、胎盘早剥(调整RR 1.01;95%CI 0.84-1.21)、发热(调整RR 0.87;95%CI 0.47-1.59)、早产(调整RR 0.83;95%CI 0.78-0.89)、早产胎膜早破(RR 1.00;95%CI 0.94-1.06)、绒毛膜羊膜炎(调整RR 1.03;95%CI 0.90-1.18)及小于胎龄儿(调整RR 0.99;95%CI 0.93-1.05)风险增加无关。妊娠间隔和疫苗类型(四价或三价)未改变上述关联。结论支持在流感季节为孕妇或可能怀孕者接种疫苗的建议。

要点

  • 连续两次妊娠均接种流感疫苗者与均未接种者相比,早产风险调整RR 0.83(95%CI 0.78-0.89),未增加风险。
  • 子痫前期或子痫调整RR 1.10(95%CI 0.99-1.21),胎盘早剥调整RR 1.01(95%CI 0.84-1.21),均未达统计学显著。
  • 发热调整RR 0.87(95%CI 0.47-1.59)、早产胎膜早破RR 1.00(95%CI 0.94-1.06)、绒毛膜羊膜炎调整RR 1.03(95%CI 0.90-1.18)、小于胎龄儿调整RR 0.99(95%CI 0.93-1.05)均未见风险增加。
  • 妊娠间隔和疫苗类型(四价或三价)未改变连续接种与不良围产结局的关联。
  • 研究结果支持在流感季节为孕妇或可能怀孕者接种流感疫苗的建议。

适用人群与场景

  • 2004年1月1日至2018年12月31日间在疫苗安全数据链中至少两次连续单胎活产妊娠的个体。
  • 接种组为连续两次妊娠均在流感季节(8月1日至4月30日)接种流感疫苗者;对照组为两次妊娠均未接种者。

研究设计与关键结果

  • 研究类型为回顾性队列研究,数据来自疫苗安全数据链(美国疾病控制与预防中心与整合医疗组织合作项目),纳入82055名有两次单胎妊娠的个体,其中44879人(54.7%)在连续两次妊娠均接种流感疫苗。
  • 接种组第二次妊娠开始时平均(SD)年龄为32.2(4.6)岁,未接种组为31.2(5.0)岁。
  • 与两次妊娠均未接种者相比,连续接种者子痫前期或子痫调整RR 1.10(95%CI 0.99-1.21),胎盘早剥调整RR 1.01(95%CI 0.84-1.21),发热调整RR 0.87(95%CI 0.47-1.59),早产调整RR 0.83(95%CI 0.78-0.89),早产胎膜早破RR 1.00(95%CI 0.94-1.06),绒毛膜羊膜炎调整RR 1.03(95%CI 0.90-1.18),小于胎龄儿调整RR 0.99(95%CI 0.93-1.05)。
  • 妊娠间隔和疫苗类型(四价或三价)未改变上述关联。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,研究结果支持在流感季节为孕妇或可能怀孕者接种流感疫苗的建议。
  • 连续两次妊娠接种流感疫苗未增加不良围产结局风险,且与妊娠间隔和疫苗类型无关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Although influenza vaccination has been found to be safe in pregnancy, few studies have assessed repeated influenza vaccination over successive pregnancies, including 2 vaccinations in a year, in terms of adverse perinatal outcomes.

OBJECTIVE: To examine the association of seasonal influenza vaccination across successive pregnancies with adverse perinatal outcomes and whether the association varies by interpregnancy interval (IPI) and vaccine type (quadrivalent or trivalent).

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included individuals with at least 2 successive singleton live-birth pregnancies between January 1, 2004, and December 31, 2018. Data were collected from the Vaccine Safety Datalink, a collaboration between the Centers for Disease Control and Prevention and integrated health care organizations. Data analysis was performed between January 8, 2021, and July 17, 2024.

EXPOSURES: Influenza vaccination was identified using vaccine administration codes. The vaccinated cohort consisted of people who received influenza vaccines during the influenza season (August 1 through April 30) in 2 successive pregnancies. The comparator cohort consisted of people identified as unvaccinated during both pregnancies.

MAIN OUTCOMES AND MEASURES: Main outcomes were risk of preeclampsia or eclampsia, placental abruption, fever, preterm birth, preterm premature rupture of membranes, chorioamnionitis, and small for gestational age among individuals with and without vaccination in both pregnancies. Adjusted relative risks (RRs) from Poisson regression were used to assess the magnitude of associations. The associations with adverse outcomes by IPI and vaccine type were evaluated.

RESULTS: Of 82 055 people with 2 singleton pregnancies between 2004 and 2018, 44 879 (54.7%) had influenza vaccination in successive pregnancies. Mean (SD) age at the start of the second pregnancy was 32.2 (4.6) years for vaccinated individuals and 31.2 (5.0) years for unvaccinated individuals. Compared with individuals not vaccinated in both pregnancies, vaccination in successive pregnancies was not associated with increased risk of preeclampsia or eclampsia (adjusted RR, 1.10; 95% CI, 0.99-1.21), placental abruption (adjusted RR, 1.01; 95% CI, 0.84-1.21), fever (adjusted RR, 0.87; 95% CI, 0.47-1.59), preterm birth (adjusted RR, 0.83; 95% CI, 0.78-0.89), preterm premature rupture of membranes (RR, 1.00; 95% CI, 0.94-1.06), chorioamnionitis (adjusted RR, 1.03; 95% CI, 0.90-1.18), or small for gestational age birth (adjusted RR, 0.99; 95% CI, 0.93-1.05). IPI and vaccine type did not modify the observed associations.

CONCLUSIONS AND RELEVANCE: In this large cohort study of successive pregnancies, influenza vaccination was not associated with increased risk of adverse perinatal outcomes, irrespective of IPI and vaccine type. Findings support recommendations to vaccinate pregnant people or those who might be pregnant during the influenza season.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Getahun D, Liu IA, Sy LS, et al. Safety of the Seasonal Influenza Vaccine in 2 Successive Pregnancies. JAMA Netw Open. 2024. PMID: 39298167. doi:10.1001/jamanetworkopen.2024.34857

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。